|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 315.30 CHF | -0.76% |
|
+0.64% | +23.41% |
| 07:05am | Roche Says Lymphoma Treatment Lunsumio Might Be Effective Earlier | DJ |
| 06:53am | European Commission Approves Roche Lupus Nephritis Treatment | DJ |
EPS & Dividend: Roche Holding AG
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 9.1 | 9.3 | 9.5 | 9.6 | 9.7 | 9.879 | 10.07 | 10.32 |
| Rate of return | 2.94% | 2.45% | 3.27% | 3.93% | 3.8% | 3.11% | 3.17% | 3.25% |
| EPS 2 | 16.52 | 16.2 | 15.37 | 14.31 | 10.31 | 17.23 | 18.93 | 20.23 |
| Distribution rate | 55.1% | 57.4% | 61.8% | 67.1% | 94.1% | 57.3% | 53.2% | 51% |
| Reference price 2 | 309.00 | 379.10 | 290.50 | 244.50 | 255.50 | 317.70 | 317.70 | 317.70 |
| Nbr of stocks (in thousands) | 854,642 | 800,952 | 800,579 | 798,652 | 796,789 | 850,317 | - | - |
| Announcement Date | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | - | - | - |
Past dividends: Roche Holding AG
| 26/03/2025 | Annual 9.7 CHF |
| 13/03/2024 | Annual 9.6 CHF |
| 15/03/2023 | Annual 9.5 CHF |
| 16/03/2022 | Annual 9.3 CHF |
| 17/03/2021 | Annual 9.1 CHF |
| 18/03/2020 | Annual 9 CHF |
| 06/03/2019 | Annual 8.7 CHF |
| 14/03/2018 | Annual 8.3 CHF |
| 15/03/2017 | Annual 8.2 CHF |
| 02/03/2016 | Annual 8.1 CHF |
Upcoming events: Roche Holding AG
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 3.11% | 3.17% | 18.44x | 6.58x | 4.63x | |
| 0.59% | 0.67% | 43.61x | 32.84x | 14.44x | |
| 2.56% | 2.65% | 19.24x | 6.18x | 5.4x | |
| 2.92% | 3.04% | 52.12x | -538.68x | 7.39x | |
| 1.78% | 1.88% | 27.22x | 6.14x | 5.16x | |
| 3.1% | 3.22% | 18.22x | 5.71x | 4.93x | |
| 3.27% | 3.42% | 12.78x | 4.56x | 4.18x | |
| 3.89% | 3.82% | 12.97x | 7.04x | 4.66x | |
| 2.97% | 3.14% | 24.54x | 19.41x | 5.99x | |
| 2.73% | 2.85% | 17.68x | 6.63x | 5.58x | |
| Average | 2.69% | 2.79% | 24.68x | -44.36x | 6.24x | |
| Weighted average by Cap. | 2.28% | 2.37% | 29.26x | -49.08x | 7.77x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition